Vivimed Labs Limited (VIVIMEDLAB) — Financial Results

· NSE Neutral

Vivimed Labs Limited clarified that its financial results for the year ended March 31, 2025 were submitted with a missing SEBI MD/CEO signature, a delayed filing due to a technical scanning issue within three hours, and discrepancies in XBRL submission requiring a revised filing. The company confirmed corrective actions and future procedural improvements to prevent recurrence.

📄 View Original Announcement (PDF)

About Vivimed Labs Limited (VIVIMEDLAB)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹61.27 Cr P/E: -4.4

View full VIVIMEDLAB stock details →

📡 Get AI alerts when VIVIMEDLAB files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track VIVIMEDLAB — Free

📊 More VIVIMEDLAB filings

See all VIVIMEDLAB filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

📡 Get AI alerts when VIVIMEDLAB files new disclosures

Track VIVIMEDLAB filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track VIVIMEDLAB — Free

Free account · 2 AI queries/day